SPHK1 and glioblastoma: On the other hand, knockdown of SphK2, but not SphK1, in U1242 and U87 MG glioblastoma cells attenuated cell proliferation and doxorubicin-induced apoptosis in MCF7 breast cancer cells [51], [52].